Clinical Trials Directory

Trials / Completed

CompletedNCT00212628

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
444 (actual)
Sponsor
Ono Pharmaceutical Co., Ltd. · Industry
Sex
Female
Age
55 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.

Conditions

Interventions

TypeNameDescription
DRUGMinodronic acid hydrate

Timeline

Start date
2004-06-01
First posted
2005-09-21
Last updated
2012-06-14

Locations

9 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00212628. Inclusion in this directory is not an endorsement.

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan (NCT00212628) · Clinical Trials Directory